These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 29442392)
21. Contribution of auditory P300 test to the diagnosis of mild cognitive impairment in Parkinson's disease. Yilmaz FT; Özkaynak SS; Barçin E Neurol Sci; 2017 Dec; 38(12):2103-2109. PubMed ID: 28887694 [TBL] [Abstract][Full Text] [Related]
22. Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study. Galtier I; Nieto A; Lorenzo JN; Barroso J J Neurol; 2019 Mar; 266(3):745-754. PubMed ID: 30635723 [TBL] [Abstract][Full Text] [Related]
23. The RAPID-II Neuropsychological Test battery for subjects aged 20 to 49 years: Norms and cognitive profile. Binetruy M; Mauny F; Lavaux M; Meyer A; Sylvestre G; Puyraveau M; Berger E; Magnin E; Vandel P; Galmiche J; Chopard G; Rev Neurol (Paris); 2018; 174(1-2):44-55. PubMed ID: 28673660 [TBL] [Abstract][Full Text] [Related]
24. Mild cognitive impairment in De Novo Parkinson's disease according to movement disorder guidelines. Poletti M; Frosini D; Ceravolo R; Bonuccelli U Mov Disord; 2012 Nov; 27(13):1706; author reply 1707. PubMed ID: 23192930 [No Abstract] [Full Text] [Related]
31. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain. Cammisuli DM; Sportiello MT Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200 [TBL] [Abstract][Full Text] [Related]
32. Strengths and challenges in conducting clinical trials in Parkinson's disease mild cognitive impairment. Litvan I; Kieburtz K; Tröster AI; Aarsland D Mov Disord; 2018 Apr; 33(4):520-527. PubMed ID: 29573469 [TBL] [Abstract][Full Text] [Related]
33. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition. Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468 [TBL] [Abstract][Full Text] [Related]
34. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up. Domellöf ME; Ekman U; Forsgren L; Elgh E Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230 [TBL] [Abstract][Full Text] [Related]
35. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. Poletti M; Frosini D; Pagni C; Baldacci F; Nicoletti V; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):601-6. PubMed ID: 22492216 [TBL] [Abstract][Full Text] [Related]
36. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic Accuracy and Confidence in the Clinical Detection of Cognitive Impairment in Early-Stage Parkinson Disease. Wyman-Chick KA; Martin PK; Barrett MJ; Manning CA; Sperling SA J Geriatr Psychiatry Neurol; 2017 May; 30(3):178-183. PubMed ID: 28351200 [TBL] [Abstract][Full Text] [Related]